Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI)

Cardiac troponin I as predictor for cardiac and other mortality in the German randomized lung cancer screening trial (LUSI)

Abstract Cardiac Troponin I (cTnI) could be used to identify individuals at elevated risk of cardiac death in lung cancer (LC) screening settings. In a population-based, randomized LC screening trial in Germany (“LUSI” study) serum cTnI was measured by high-sensitivity assay in blood samples collect...

Full description

Bibliographic Details
Main Authors: Francisco O. Cortés-Ibáñez, Theron Johnson, Mario Mascalchi, Verena Katzke, Stefan Delorme, Rudolf Kaaks
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Subjects:
Troponin
Biomarkers
Lung cancer screening
Myocardial infarction
Mortality
Risk assessment
Online Access:https://doi.org/10.1038/s41598-024-57889-z

Internet

https://doi.org/10.1038/s41598-024-57889-z

Similar Items